GDNF-induced leukemia inhibitory factor can mediate differentiation via the MEK/ERK pathway in pheochromocytoma cells derived from nf1-heterozygous knockout mice

Experimental Cell Research

Volumn 303, Issue 1, 2005, Pages 79-88

  Park, Jong In ^a   Powers, James F ^b   Tischler, Arthur S ^b   Strock, Christopher J ^a   Ball, Douglas W ^a,c   Nelkin, Barry D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autocrine paracrine; Differentiation; GDNF; LIF; MEK ERK; NF1; Pheochromocytoma; Signaling

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BROXURIDINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROMODULIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; MOUSE; NERVE CELL; NONHUMAN; PARACRINE SIGNALING; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

MURINAE;

EID: 9644295588     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.09.028     Document Type: Article

References (64)

1. S.A. Rasmussen, and J.M. Friedman NF1 gene and neurofibromatosis 1 Am. J. Epidemiol. 151 2000 33 40
2. K.M. Shannon, P. O'Connell, G.A. Martin, D. Paderanga, K. Olson, P. Dinndorf, and F. McCormick Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders N. Engl. J. Med. 330 1994 597 601
3. D.H. Gutmann, J.L. Cole, W.J. Stone, B.A. Ponder, and F.S. Collins Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I Genes Chromosomes Cancer 10 1994 55 58
4. C.A. Koch, A.O. Vortmeyer, S.C. Huang, S. Alesci, Z. Zhuang, and K. Pacak Genetic aspects of pheochromocytoma Endocr. Regul. 35 2001 43 52
5. C.A. Koch, A.O. Vortmeyer, Z. Zhuang, F.M. Brouwers, and K. Pacak New insights into the genetics of familial chromaffin cell tumors Ann. N. Y. Acad. Sci. 970 2002 11 28
6. V.M. Riccardi Von Recklinghausen neurofibromatosis N. Engl. J. Med. 305 1981 1617 1627
7. S.M. Huson, D.A. Compston, and P.S. Harper A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counseling J. Med. Genet. 26 1989 712 721
8. A.S. Tischler, T.S. Shih, B.O. Williams, and T. Jacks Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1 Endocr. Pathol. 6 1995 323 335
9. J.F. Powers, M.J. Evinger, P. Tsokas, S. Bedri, J. Alroy, M. Shahsavari, and A.S. Tischler Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice Cell Tissue Res. 302 2000 309 320
10. T. Jacks, T.S. Shih, E.M. Schmitt, R.T. Bronson, A. Bernards, and R.A. Weinberg Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 Nat. Genet. 7 1994 353 361
11. M.S. Airaksinen, A. Titievsky, and M. Saarma GDNF family neurotrophic factor signaling: four masters, one servant? Mol. Cell. Neurosci. 13 1999 313 325
12. J.R. Hansford, and L.M. Mulligan Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis J. Med. Genet. 37 2000 817 827
13. J.F. Powers, K.H. Schelling, J.M. Brachold, and A.S. Tischler Plasticity of pheochromocytoma cell lines from neurofibromatosis knockout mice Ann. N. Y. Acad. Sci. 971 2002 371 378
14. R.F. Newbold, and R.W. Overell Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-Ras oncogene Nature 304 1983 648 651
15. B.R.J. Franza, K. Maruyama, J.I. Garrels, and H.E. Ruley In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes Cell 44 1986 409 418
16. A.J. Ridley, H.F. Paterson, M. Noble, and H. Land Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation EMBO J. 7 1988 1635 1645
17. A.C. Lloyd, F. Obermuller, S. Staddon, C.F. Barth, M. McMahon, and H. Land Cooperating oncogenes converge to regulate cyclin/cdk complexes Genes Dev. 11 1997 663 677
18. M. Serrano, A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a Cell 88 1997 593 602
19. A. Sewing, B. Wiseman, A.C. Lloyd, and H. Land High-intensity Raf signal causes cell cycle arrest mediated by p21cip1 Mol. Cell. Biol. 17 1997 5588 5597
20. cip1 Mol. Cell. Biol. 17 1997 5598 5611
21. J. Zhu, D. Woods, M. McMahon, and J.M. Bishop Senescence of human fibroblasts induced by oncogenic Raf Genes Dev. 12 1998 2997 3007
22. Kip1 without activating cyclin D-dependent kinases J. Biol. Chem. 275 2000 27473 27480
23. M. Malumbres, I. Perez De Castro, M.I. Hernandez, M. Jimenez, T. Corral, and A. Pellicer Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b) Mol. Cell. Biol. 20 2000 2915 2925
24. C.P. Fanton, M. McMahon, and R.O. Pieper Dual growth arrest pathways in astrocytes and astrocytic tumors in response to Raf-1 activation J. Biol. Chem. 276 2001 18871 18877
25. ARF- independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes EMBO Rep. 2 2001 145 150
26. C.L. Olsen, B. Gardie, P. Yaswen, and M.R. Stampfer Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion Oncogene 21 2002 6328 6339
27. K.W. Wood, H. Qi, G. D'Arcangelo, R.C. Armstrong, T.M. Roberts, and S. Halegoua The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction Proc. Natl. Acad. Sci. U. S. A. 90 1993 5016 5020
28. E.B. Carson, M. McMahon, S.B. Baylin, and B.D. Nelkin Ret gene silencing is associated with Raf-1 induced medullary thyroid carcinoma cell differentiation Cancer Res. 55 1995 2048 2052
29. R.K. Ravi, E. Weber, M. McMahon, J.R. Williams, S. Baylin, A. Mal, M.L. Harter, L.E. Dillehay, P.P. Claudio, A. Giordano, B.D. Nelkin, and M. Mabry Activated Raf-1 causes growth arrest in human small cell lung cancer cells J. Clin. Invest. 101 1998 153 159
30. R.K. Ravi, A. Thiagalingam, E. Weber, M. McMahon, B.D. Nelkin, and M. Mabry Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small cell lung cancer cells Am. J. Respir. Cell Mol. Biol. 20 1999 543 549
31. R.K. Ravi, M. McMahon, Z. Yangang, J.R. Williams, L.E. Dillehay, B.D. Nelkin, and M. Mabry Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells J. Cell. Biochem. 72 1999 458 469
32. J.I. Park, C.J. Strock, D.W. Ball, and B.D. Nelkin The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway Mol. Cell. Biol. 23 2003 543 554
33. T.S. Lewis, J.B. Hunt, L.D. Aveline, K.R. Jonscher, D.F. Louie, J.M. Yeh, T.S. Nahreini, K.A. Resing, and N.G. Ahn Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry Mol. Cell. 6 2000 1343 1354
34. T.C. He, S. Zhou, L.T. da Costa, J. Yu, K.W. Kinzler, and B. Vogelstein A simplified system for generating recombinant adenoviruses Proc. Natl. Acad. Sci. U. S. A. 95 1998 2509 2514
35. J.F. Powers, K. Schelling, J.M. Brachold, P. Tsokas, H. Schayek, E. Friedman, and A.S. Tischler High-level expression of receptor tyrosine kinase Ret and responsiveness to Ret-activating ligands in pheochromocytoma cell lines from neurofibromatosis knockout mice Mol. Cell. Neurosci. 20 2002 382 389
36. C. Bousquet, and S. Melmed Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling J. Biol. Chem. 274 1999 10723 10730
37. C.J. Auernhammer, and S. Melmed Leukemia inhibitory factor-neuroimmune modulator of endocrine function Endocrine Rev. 21 2000 313 345
38. J. Aubert, S. Dessolin, N. Belmonte, M. Li, F.R. McKenzie, L. Staccini, P. Villageois, B. Barhanin, A. Vernallis, A.G. Smith, G. Ailhaud, and C. Dani Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade J. Biol. Chem. 274 1999 24965 24972
39. R.L. Nicol, N. Frey, G. Pearson, M. Cobb, J. Richardson, and E.N. Olson Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy EMBO J. 20 2001 2757 2767
40. J.M. Stephens, S.J. Lumpkin, and J.B. Fishman Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes J. Biol. Chem. 273 1998 31408 31416
41. T. Kato, M. Sano, S. Miyoshi, T. Sato, D. Hakuno, H. Ishida, H. Kinoshita-Nakazawa, K. Fukuda, and S. Ogawa Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats Circ. Res. 87 2000 937 945
42. Y. Ma, R.B. Campenot, and F.D. Miller Concentration-dependent regulation of neuronal gene expression by nerve growth factor J. Cell Biol. 117 1992 135 141
43. J.F. Powers, M. Shahsavari, P. Tsokas, and A.S. Tischler Nerve growth factor receptor signaling in proliferation of normal adult rat chromaffin cells Cell Tissue Res. 295 1999 21 32
44. J. Barasch, J. Yang, C.B. Ware, T. Taga, K. Yoshida, H. Erdjument-Bromage, P. Tempst, E. Parravicini, S. Malach, T. Aranoff, and J.A. Oliver Mesenchymal to epithelial conversion in rat metanephros is induced by LIF Cell 99 1999 377 386
45. G.F. Xu, P. O'Connell, D. Viskochil, R. Cawthon, M. Robertson, M. Culver, D. Dunn, J. Stevens, R. Gesteland, R. White, and R. Weiss The neurofibromatosis type 1 gene encodes a protein related to GAP Cell 62 1990 599 608
46. J.E. DeClue, A.G. Papageorge, J.A. Fletcher, S.R. Diehl, N. Ratner, W.C. Vass, and D.R. Lowy Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis Cell 69 1992 265 273
47. T.N. Basu, D.H. Gutmann, J.A. Fletcher, T.W. Glover, F.S. Collins, and J. Downward Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients Nature 356 1992 713 715
48. G. Bollag, D.W. Clapp, S. Shih, F. Adler, Y.Y. Zhang, P. Thompson, B.J. Lange, M.H. Freedman, F. McCormick, T. Jacks, and K. Shannon Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells Nat. Genet. 12 1996 144 148
49. M.L. Bajenaru, J. Donahoe, T. Corral, K.M. Reilly, S. Brophy, A. Pellicer, and D.H. Gutmann Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes Glia 33 2001 314 323
50. B. Weiss, G. Bollag, and K. Shannon Hyperactive Ras as a therapeutic target in neurofibromatosis type 1 Am. J. Med. Genet. 89 1999 14 22
51. T. Corral, M. Jimenez, I. Hernandez-Munoz, I. Perez de Castro, and A. Pellicer NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity J. Cell. Physiol. 197 2003 214 224
52. J. Tong, F. Hannan, Y. Zhu, A. Bernards, and Y. Zhong Neurofibromin regulates G protein-stimulated adenylyl cyclase activity Nat. Neurosci. 5 2002 95 96
53. Y. Zhu, P. Ghosh, P. Charnay, D.K. Burns, and L.F. Parada Neurofibromas in NF1: Schwann cell origin and role of tumor environment Science 296 2002 920 922
54. F.C. Yang, D.A. Ingram, S. Chen, C.M. Hingtgen, N. Ratner, K.R. Monk, T. Clegg, H. White, L. Mead, M.J. Wenning, D.A. Williams, R. Kapur, S.J. Atkinson, and D.W. Clapp Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells J. Clin. Invest. 112 2003 1851 1861
55. M. Satoh, and T. Yoshida Promotion of neurogenesis in mouse olfactory neuronal progenitor cells by leukemia inhibitory factor in vitro Neurosci. Lett. 225 1997 165 168
56. S. Bauer, S. Rasika, J. Han, C. Mauduit, M. Raccurt, G. Morel, F. Jourdan, M. Benahmed, E. Moyse, and P.H. Patterson Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium J. Neurosci. 23 2003 1792 1803
57. C. Moon, J.Y. Yoo, V. Matarazzo, Y.K. Sung, E.J. Kim, and G.V. Ronnett Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation Proc. Natl. Acad. Sci. U. S. A. 99 2002 9015 9020
58. K. Krieglstein, F. Deimling, C. Suter-Crazzolara, and K. Unsicker Expression and localization of GDNF in developing and adult adrenal chromaffin cells Cell Tissue Res. 286 1996 263 268
59. G. Kontogeorgos, B.W. Scheithauer, K. Kovacs, E. Horvath, and S. Melmed Growth factors and cytokines in paragangliomas and pheochromocytomas, with special reference to sustentacular cells Endocr. Pathol. 13 2002 197 206
60. D.J. Vandenbergh, N. Mori, and D.J. Anderson Co-expression of multiple neurotransmitter enzyme genes in normal and immortalized sympathoadrenal progenitor cells Dev. Biol. 148 1991 10 22
61. S. Biffo, J. Verhaagen, L.H. Schrama, P. Schotman, W. Danho, and F.L. Margolis B-50/GAP43 expression correlates with process outgrowth in the embryonic mouse nervous system Eur. J. Neurosci. 2 1990 487 499
62. K.H. Pfenninger, B.A. de la Houssaye, S.M. Helmke, and S. Quiroga Growth-regulated proteins and neuronal plasticity. A commentary Mol. Neurobiol. 5 1991 143 151
63. S.L. Donovan, L.A. Mamounas, A.M. Andrews, M.E. Blue, and J.S. McCasland GAP-43 is critical for normal development of the serotonergic innervation in forebrain J. Neurosci. 22 2002 3543 3552
64. D. Frey, T. Laux, L. Xu, C. Schneider, and P. Caroni Shared and unique roles of CAP23 and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity J. Cell Biol. 149 2000 1443 1454